UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 91

Sortiert nach

Preexisting autoantibodies as predictor of immune related adverse events (irAEs) for advanced solid tumors treated with immune checkpoint inhibitors (ICIs)

Oncoimmunology, 2023-12, Vol.12 (1), p.2204754-2204754

2023

Volltextzugriff (PDF)

Anti‐Factor H Autoantibodies in a Fifth Renal Transplant Recipient with Atypical Hemolytic and Uremic Syndrome

American journal of transplantation, 2009-05, Vol.9 (5), p.1223-1229

2009

Volltextzugriff (PDF)

Contribution of antiphosphatidylserine/prothrombin (anti-PS/PT) antibody detection in the diagnosis and management of antiphospholipid syndrome (APS)

La revue de medecine interne, 2022-09, Vol.43 (9), p.545-551

2022

Volltextzugriff (PDF)

The development of atypical haemolytic-uraemic syndrome is influenced by susceptibility factors in factor H and membrane cofactor protein: evidence from two independent cohorts

Journal of medical genetics, 2005-11, Vol.42 (11), p.852-856

2005

Volltextzugriff (PDF)

Increased Performances of the Biological Diagnosis of the Antiphospholipid Syndrome by the Use of a Multiplex Assay

Journal of Immunology Research, 2015-01, Vol.2015, p.983094-9

2015

Volltextzugriff (PDF)

Laboratory diagnosis of antiphospholipid syndrome: From criteria to practice

La revue de medecine interne, 2018-01, Vol.39 (1), p.34-41

2018

Volltextzugriff (PDF)

Complement factor I: a susceptibility gene for atypical haemolytic uraemic syndrome

Journal of medical genetics, 2004-06, Vol.41 (6), p.e84-e84

2004

Volltextzugriff (PDF)

Clinical response and pharmacodynamic assessment of INVAC-1, a DNA plasmid encoding an inactive form of human telomerase reverse transcriptase (hTERT), on immune responses, immune tolerability, tumor burden and circulating tumor DNA (ctDNA) in patients with advanced solid tumors

Annals of oncology, 2018-10, Vol.29 Suppl 8, p.viii136

2018

Volltextzugriff (PDF)

Restricted genetic defects underlie human complement C6 deficiency

Clinical and experimental immunology, 2003-04, Vol.132 (1), p.87-91

2003

Volltextzugriff (PDF)

Targeting renin-angiotensin system in malignant hypertension in atypical hemolytic uremic syndrome

Indian journal of nephrology, 2017-03, Vol.27 (2), p.136-140

2017

Volltextzugriff (PDF)

Atypical haemolytic uraemic syndrome and mutations in complement regulator genes

Seminars in immunopathology, 2005-11, Vol.27 (3), p.359-374

2005

Volltextzugriff (PDF)

The high frequency of complement factor H related CFHR1 gene deletion is restricted to specific subgroups of patients with atypical haemolytic uraemic syndrome

Journal of medical genetics, 2009-07, Vol.46 (7), p.447-450

2009

Volltextzugriff (PDF)

Eculizumab for atypical hemolytic-uremic syndrome in India: First report from India and the challenges faced

Indian journal of nephrology, 2017-01, Vol.27 (1), p.58-61

2017

Volltextzugriff (PDF)

Lack of evidence of a specific role for C4A gene deficiency in determining disease susceptibility among C4‐deficient patients with systemic lupus erythematosus (SLE)

Clinical and experimental immunology, 2001-01, Vol.123 (1), p.133-139

2001

Volltextzugriff (PDF)

Clinical significance of anti-Ro52 (TRIM21) antibodies non-associated with anti-SSA 60kDa antibodies: Results of a multicentric study

Autoimmunity reviews, 2011-07, Vol.10 (9), p.509-513

2011

Volltextzugriff (PDF)

Clinical significance of anti-Ro52 (TRIM21) antibodies non-associated with anti-SSA 60 kDa antibodies: Results of a multicentric study

Autoimmunity reviews, 2011-07, Vol.10 (9), p.509-513

2011

Volltextzugriff (PDF)

Molecular Basis of a Selective C1s Deficiency Associated with Early Onset Multiple Autoimmune Diseases

The Journal of immunology (1950), 2001-06, Vol.166 (12), p.7612-7616

2001

Volltextzugriff (PDF)

Non-Hodgkin's lymphomas and myeloid disorders : deletions associated with t(2;5) and t(3;5) detected by FISH

Leukemia, 1998-07, Vol.12 (7), p.1159-1162

1998

Volltextzugriff (PDF)

Hereditary angio-oedema: effective treatment with the progestogen-only pill in a young woman

British journal of dermatology (1951), 2004-09, Vol.151 (3), p.713-714

2004

Volltextzugriff (PDF)

Atypical hemolytic-uremic syndrome related to abnormalities within the complement system

La revue de medecine interne, 2011-04, Vol.32 (4), p.232-240

2011

Volltextzugriff (PDF)

Imbalance between alpha-1-antitrypsin and interleukin 6 is associated with in-hospital mortality and thrombosis during COVID-19

Biochimie, 2022-11, Vol.202, p.206-211

2022

Volltextzugriff (PDF)

Syndrome hémolytique et urémique lié à des anomalies du complément

La revue de medecine interne, 2011-04, Vol.32 (4), p.232-240

2011

Volltextzugriff (PDF)

Anti-factor H autoantibodies associated with atypical hemolytic uremic syndrome

Journal of the American Society of Nephrology, 2005-02, Vol.16 (2), p.555-563

2005

Volltextzugriff (PDF)

Successful pre-transplant management of a patient with anti-factor H autoantibodies-associated haemolytic uraemic syndrome

Nephrology, dialysis, transplantation, 2008-06, Vol.23 (6), p.2088-2090

2008

Volltextzugriff (PDF)

Heterozygous and homozygous factor H deficiencies associated with hemolytic uremic syndrome or membranoproliferative glomerulonephritis: Report and genetic analysis of 16 cases

Journal of the American Society of Nephrology, 2004-03, Vol.15 (3), p.787-795

2004

Volltextzugriff (PDF)

1 – 25 von 91

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(83)
Mit Volltextzugriff
(77)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(38)
Life Sciences & Biomedicine
(37)
Humans
(36)
Female
(20)
Male
(17)
Biological And Medical Sciences
(16)
Medical Sciences
(16)
Immunology
(15)
Child
(14)
Complement
(13)
Hemolytic-Uremic Syndrome - Genetics
(13)
Adult
(11)
Child, Preschool
(11)
Nephrology. Urinary Tract Diseases
(11)
Nephropathies. Renovascular Diseases. Renal Failure
(11)
Adolescent
(10)
Hemolytic-Uremic Syndrome - Immunology
(10)
Mutation
(10)
Complement Factor H - Immunology
(9)
Renal Failure
(9)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Preexisting autoantibodies as predictor of immune related adverse events (irAEs) for advanced solid tumors treated with immune checkpoint inhibitors (ICIs)

Anti‐Factor H Autoantibodies in a Fifth Renal Transplant Recipient with Atypical Hemolytic and Uremic Syndrome

Contribution of antiphosphatidylserine/prothrombin (anti-PS/PT) antibody detection in the diagnosis and management of antiphospholipid syndrome (APS)

The development of atypical haemolytic-uraemic syndrome is influenced by susceptibility factors in factor H and membrane cofactor protein: evidence from two independent cohorts

Increased Performances of the Biological Diagnosis of the Antiphospholipid Syndrome by the Use of a Multiplex Assay

Laboratory diagnosis of antiphospholipid syndrome: From criteria to practice

Complement factor I: a susceptibility gene for atypical haemolytic uraemic syndrome

Clinical response and pharmacodynamic assessment of INVAC-1, a DNA plasmid encoding an inactive form of human telomerase reverse transcriptase (hTERT), on immune responses, immune tolerability, tumor burden and circulating tumor DNA (ctDNA) in patients with advanced solid tumors

Restricted genetic defects underlie human complement C6 deficiency

Targeting renin-angiotensin system in malignant hypertension in atypical hemolytic uremic syndrome

Atypical haemolytic uraemic syndrome and mutations in complement regulator genes

The high frequency of complement factor H related CFHR1 gene deletion is restricted to specific subgroups of patients with atypical haemolytic uraemic syndrome

Eculizumab for atypical hemolytic-uremic syndrome in India: First report from India and the challenges faced

Lack of evidence of a specific role for C4A gene deficiency in determining disease susceptibility among C4‐deficient patients with systemic lupus erythematosus (SLE)

Clinical significance of anti-Ro52 (TRIM21) antibodies non-associated with anti-SSA 60kDa antibodies: Results of a multicentric study

Clinical significance of anti-Ro52 (TRIM21) antibodies non-associated with anti-SSA 60 kDa antibodies: Results of a multicentric study

Molecular Basis of a Selective C1s Deficiency Associated with Early Onset Multiple Autoimmune Diseases

Non-Hodgkin's lymphomas and myeloid disorders : deletions associated with t(2;5) and t(3;5) detected by FISH

Hereditary angio-oedema: effective treatment with the progestogen-only pill in a young woman

Atypical hemolytic-uremic syndrome related to abnormalities within the complement system

Imbalance between alpha-1-antitrypsin and interleukin 6 is associated with in-hospital mortality and thrombosis during COVID-19

Syndrome hémolytique et urémique lié à des anomalies du complément

Anti-factor H autoantibodies associated with atypical hemolytic uremic syndrome

Successful pre-transplant management of a patient with anti-factor H autoantibodies-associated haemolytic uraemic syndrome

Heterozygous and homozygous factor H deficiencies associated with hemolytic uremic syndrome or membranoproliferative glomerulonephritis: Report and genetic analysis of 16 cases

Suchergebnisse filtern